News

The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...
The Food and Drug Administration has approved a first of its kind, once-yearly shot designed to protect dogs from fleas and ...
A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...
Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...
The U.S. Food and Drug Administration (FDA) approved Bravecto Quantum, a novel injectable treatment offering dogs up to 12 months of protection against fleas and ticks with a single dose.
FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.